Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$135.68 - $176.11 $4.03 Million - $5.23 Million
29,700 New
29,700 $4.66 Million
Q1 2022

May 17, 2022

SELL
$12.58 - $26.94 $449,106 - $961,758
-35,700 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$19.16 - $32.68 $321,888 - $549,024
-16,800 Reduced 32.0%
35,700 $684,000
Q3 2021

Nov 16, 2021

BUY
$25.92 - $34.51 $790,560 - $1.05 Million
30,500 Added 138.64%
52,500 $1.74 Million
Q2 2021

Aug 16, 2021

BUY
$21.63 - $40.07 $475,860 - $881,540
22,000 New
22,000 $730,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.82B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.